Cargando…
Cardiac Sympathetic Hyperactivity after Chemotherapy: Early Sign of Cardiotoxicity?
BACKGROUND: Chemotherapy with anthracyclines and trastuzumab can cause cardiotoxicity. Alteration of cardiac adrenergic function assessed by metaiodobenzylguanidine labeled with iodine-123 ((123)I-mIBG) seems to precede the drop in left ventricular ejection fraction. OBJECTIVE: To evaluate and to co...
Autores principales: | Guimarães, Sarita Lígia Pessoa de Melo Machado, Brandão, Simone Cristina Soares, Andrade, Luciana Raposo, Maia, Rafael José Coelho, Markman Filho, Brivaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592170/ https://www.ncbi.nlm.nih.gov/pubmed/26176188 http://dx.doi.org/10.5935/abc.20150075 |
Ejemplares similares
-
Speckle-Tracking Echocardiography - Ready for Use in Acute Coronary
Syndrome?
por: Markman Filho, Brivaldo
Publicado: (2018) -
Three-dimensional Speckle Tracking Echocardiography in Amyloidosis: A
New Assessment Method for a Rare Disease
por: Markman Filho, Brivaldo
Publicado: (2018) -
Thrombosis of the Vein of Galen: Pitfalls, Metamorphosis, and Paroxysmal Sympathetic Hyperactivity
por: Santos-Soares, Paulo César, et al.
Publicado: (2017) -
Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
por: Chaves-Markman, Ândrea, et al.
Publicado: (2020) -
Sympathetic hyperactivity in children of hypertensive parents
por: Rathi, Preeti, et al.
Publicado: (2013)